FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Reverse Calif. Consumer Protection Regime: WLF

Washington Legal Foundation asks the Supreme Court to reverse a California appeals court decision that hit Ethicon with $300 million in civil penaltie...

Human Drugs

Genentechs Lunsumio OKd for Some Lymphomas

FDA gives accelerated approval to Genentechs Lunsumio to treat some forms of follicular lymphoma.

Human Drugs

FDA Approves Gileads Sunlenca for Some HIV Patients

FDA approves Gileads Sunlenca, the first in a new class of drugs to treat some HIV-1 patients.

latest-news-card-1
Human Drugs

REMS Document Technical Conformance Guide

FDA publishes a technical conformance guide for its guidance on the format and content of a REMS document.

latest-news-card-1
Medical Devices

Jet Medical, Other Companies, Pay $700,000 in Device Cases

Jet Medical and two related companies agree to pay $700,000 to resolve criminal and civil charges involving Jets distribution of unapproved medical de...

latest-news-card-1
Human Drugs

Checkpoint Therapeutics BLA for Skin Cancer

Checkpoint Therapeutics files a BLA for cosibelimab, an investigational anti-PD-L1 antibody for treating patients with metastatic cutaneous squamous c...

latest-news-card-1
Medical Devices

Medical Device Consensus Standards Database Updated

FDA updates the CDRH Recognized Consensus Standards database, adding List 59.

latest-news-card-1
Human Drugs

FDA Changes Mifepristone REMS

FDA modifies the mifepristone REMS to remove the in-person dispensing requirement and permit dispensing by certified pharmacies.

latest-news-card-1
FDA General

FDA Reforms Included in Year-end Omnibus Bill

In addition to a $226 million boost in FDA spending levels, the year-end omnibus spending bill also includes notable agency reforms that were once par...

latest-news-card-1
Human Drugs

Accord Healthcare Recalls 2 Daptomycin Products

FDA says Accord Healthcare recalled one lot of daptomycin for injection due to a labeling mix-up.